Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Standard BioTools Inc LAB

Technology Scientific & Technical Instruments
Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. The Company's segments include Proteomics and Genomics. The Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. The Company provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company also provides differentiated multi-omics tools for research.


NDAQ:LAB - Post by User

Standard BioTools Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(77)
•••
Post by Humaniston Sep 30, 2020 2:15pm
84 Views
Post# 31642845

FLDM near the top of hte diagnostics & research industry!

FLDM near the top of hte diagnostics & research industry!Is Fluidigm Corporation (FLDM) Stock Near the Top of the Diagnostics & Research Industry?

Wednesday, September 30, 2020 8:23 AM | InvestorsObserver Analysts
 
Fluidigm CorporationFLDM is the highest overall rated company in the Diagnostics & Research industry with an overall score of 89. FLDM is up 74.55% so far this year after the company closed yesterday at $7.68. The overall score measures the company's performance based-off both short and long term indicators and means that FLDM scores better than 89% of the overall market.
 
FLDM has an Overall Score of 89. Find out what this means to you and get the rest of the rankings on FLDM!

See Full FLDM Report
Fluidigm Corporation is a strong performer in the Diagnostics & Research industry, which has an average overall score of 46. This means that, on average, the stocks in this industry score higher than 46% of the stock market.
To see InvestorsObserver's Sentiment Score for Fluidigm Corporation click here.
FLDM has been trading bullishly recently. The stock is trading down -8.57% this week following yesterday's decline. FLDM has an average analyst ranking of Strong Buy with an average price target of $14.
Click Here to get the full Stock Score Report on Fluidigm Corporation (FLDM) Stock.
https://www.investorsobserver.com/news/stock-update/is-fluidigm-corporation-fldm-stock-near-the-top-of-the-diagnostics-research-industry-2

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities